Sign In
Buy EVLO
Evelo Biosciences Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 11.63M and sold 73.72K EVLO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
0 |
| ● Buy | 11.63M shares |
| ● Sell | 73.72K shares |
|
76% Buy Activity
Negligible or No Correlation
|
|
No Significant SignalsNo statistically significant buy or sell signals detected in recent insider data. |
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Nov 08, 2023 Sell |
Bodmer Mark Cso, President Of R&d |
3 163 Value: $1K |
||
|
Nov 08, 2023 Sell |
Mchale Duncan Chief Medical Officer |
3 103 Value: $1K |
||
|
Nov 08, 2023 Sell |
Gill Simba President & CEO |
172 Value: $57 |
||
|
Nov 08, 2023 Sell |
Thorell Marella Chief Financial Officer |
1 811 Value: $598 |
||
|
Nov 08, 2023 Sell |
Thorell Marella Chief Financial Officer |
1 811 Value: $598 |
||
|
Nov 08, 2023 Sell |
Gill Simba President & CEO |
172 Value: $57 |
||
|
Nov 08, 2023 Sell |
Mchale Duncan Chief Medical Officer |
3 103 Value: $1K |
||
|
Nov 08, 2023 Sell |
Bodmer Mark Cso, President Of R&d |
3 163 Value: $1K |
||
|
Nov 07, 2023 Buy |
Bodmer Mark Cso, President Of R&d |
6 625 Value: $0 |
||
|
Nov 07, 2023 Buy |
Bodmer Mark Cso, President Of R&d |
6 625 Value: $0 |
||
|
Nov 07, 2023 Buy |
Mchale Duncan Chief Medical Officer |
6 500 Value: $0 |
||
|
Nov 07, 2023 Buy |
Mchale Duncan Chief Medical Officer |
6 500 Value: $0 |
||
|
Nov 07, 2023 Buy |
Gill Simba President & CEO |
1 172 Value: $0 |
||
|
Nov 07, 2023 Buy |
Gill Simba President & CEO |
1 172 Value: $0 |
||
|
Nov 07, 2023 Buy |
Thorell Marella Chief Financial Officer |
6 500 Value: $0 |
||
|
Nov 07, 2023 Buy |
Thorell Marella Chief Financial Officer |
6 500 Value: $0 |
||
|
Nov 07, 2023 Buy |
Thorell Marella Chief Financial Officer |
6 500 Value: $0 |
||
|
Nov 07, 2023 Buy |
Thorell Marella Chief Financial Officer |
6 500 Value: $0 |
||
|
Nov 07, 2023 Buy |
Gill Simba President & CEO |
1 172 Value: $0 |
||
|
Nov 07, 2023 Buy |
Gill Simba President & CEO |
1 172 Value: $0 |
||
|
Nov 07, 2023 Buy |
Mchale Duncan Chief Medical Officer |
6 500 Value: $0 |
||
|
Nov 07, 2023 Buy |
Mchale Duncan Chief Medical Officer |
6 500 Value: $0 |
||
|
Nov 07, 2023 Buy |
Bodmer Mark Cso, President Of R&d |
6 625 Value: $0 |
||
|
Nov 07, 2023 Buy |
Bodmer Mark Cso, President Of R&d |
6 625 Value: $0 |
||
|
Nov 02, 2023 Sell |
Bodmer Mark Cso, President Of R&d |
6 854 Value: $2K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
